Finance

Lists
ALMKT:EPA
Mauna Kea Technologies SA
€ 0.091
-1.19%
(-0.0011) 1D
11-р сарын 16, 17:35:09 (GMT+1)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALMKT...
Open
€ 0.09
High
€ 0.09
Low
€ 0.09
Mkt. cap
18.26 сая
Avg. vol.
484.45 мян
Volume
377.60 мян
P/E ratio
0.78
52-wk high
€ 0.23
52-wk low
€ 0.07
EPS
€ 0.12
Shares outstanding
195.26 сая
No. of employees
56
Open
€ 0.09
High
€ 0.09
Low
€ 0.09
Mkt. cap
18.26 сая
Avg. vol.
484.45 мян
Volume
377.60 мян
P/E ratio
0.78
52-wk high
€ 0.23
52-wk low
€ 0.07
EPS
€ 0.12
Shares outstanding
195.26 сая
No. of employees
56
News stories
From web sources and news partners
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts. The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues. Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time. Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA
CEOSacha Loiseau
Employees56
Founded2000
Headquarters-
SectorHealth Care
Industry-
Last report
2026 оны 7-р сарын 21
Fiscal period
Q2 2026
- / -
Revenue / Est. (EUR)
1.75 сая / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.44 сая
2.44 сая
1.75 сая
1.75 сая
Cost of goods sold
528.00 мян
528.00 мян
494.50 мян
494.50 мян
Cost of revenue
528.00 мян
528.00 мян
494.50 мян
494.50 мян
Research and development expenses
861.00 мян
861.00 мян
796.00 мян
796.00 мян
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.89 сая
1.89 сая
2.13 сая
2.13 сая
Operating expense
3.11 сая
3.11 сая
3.33 сая
3.33 сая
Total operating expenses
3.64 сая
3.64 сая
3.83 сая
3.83 сая
Operating income
-1.20 сая
-1.20 сая
-2.08 сая
-2.08 сая
Other non operating income
10.84 сая
10.84 сая
-236.00 мян
-236.00 мян
EBT including unusual items
7.69 сая
7.69 сая
-2.41 сая
-2.41 сая
EBT excluding unusual items
8.06 сая
8.06 сая
-2.41 сая
-2.41 сая
Income tax expense
-35.50 мян
-35.50 мян
-
-
Effective tax rate
-0.46%
-0.46%
-
-
Other operating expenses
92.00 мян
92.00 мян
95.00 мян
95.00 мян
Net income
7.72 сая
7.72 сая
-2.41 сая
-2.41 сая
Net profit margin
316.50%
316.50%
-137.65%
-137.65%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-490.50 мян
-490.50 мян
-25.50 мян
-25.50 мян
Net interest expenses
-490.50 мян
-490.50 мян
-25.50 мян
-25.50 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.11 сая
-1.11 сая
-2.04 сая
-2.04 сая
Gain or loss from assets sale
281.00 мян
281.00 мян
-
-
Upcoming events
AI content may include mistakes. Learn more
Google аппс